↓ Skip to main content

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

Overview of attention for article published in BMC Cancer, March 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
Published in
BMC Cancer, March 2016
DOI 10.1186/s12885-016-2162-z
Pubmed ID
Authors

Melanie Mediavilla-Varela, Kingsley Boateng, David Noyes, Scott J. Antonia

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 14%
Student > Master 9 14%
Researcher 8 12%
Student > Bachelor 6 9%
Student > Doctoral Student 4 6%
Other 12 18%
Unknown 18 27%
Readers by discipline Count As %
Medicine and Dentistry 14 21%
Biochemistry, Genetics and Molecular Biology 12 18%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Agricultural and Biological Sciences 4 6%
Unspecified 2 3%
Other 5 8%
Unknown 22 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2022.
All research outputs
#8,269,042
of 26,017,215 outputs
Outputs from BMC Cancer
#2,249
of 9,126 outputs
Outputs of similar age
#107,466
of 316,584 outputs
Outputs of similar age from BMC Cancer
#42
of 178 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 9,126 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 178 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.